Cell & Gene Therapy
Contract Development and Manufacturing Organisation (CDMO)
Product Development, Launch & Supply
Enabling healthcare companies to launch and supply products
Cell & Gene Therapy | Pharmaceutical | Biotechnology | Medical Device
Your Commercialisation Journey
The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under Ireland’s National Development Plan (NDP) in 2018. On Thursday 23rd November, Ireland’s Minister for Enterprise, Trade and Employment, Simon Coveney TD, Minister for Further...
Hitech Health is delighted to be attending Advanced Therapies Integrates in Stevenage, England on the 30th November. This event aims to drive the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies,...
Afortiori Development and HiTech Health Forge an Important Collaboration to Support the Clinical Research and Product Development of Groundbreaking Cell and Gene Therapies. Galway, November 9, 2023 - Afortiori Development, a premier full-service Clinical Research...
Stay Up To Date
Connect with us to receive the latest HiTech Health and industry updates.